These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34309550)

  • 21. Telomerase activity and cell proliferation index in cholesteatoma.
    Lee SH; Jang YH; Tae K; Park YW; Kang MJ; Kim KR; Park CW
    Acta Otolaryngol; 2005 Jul; 125(7):707-12. PubMed ID: 16012031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recidivous cholesteatoma: DWI MR after canal wall up and canal wall down mastoidectomy.
    Bakaj T; Zbrozkova LB; Salzman R; Tedla M; Starek I
    Bratisl Lek Listy; 2016; 117(9):515-520. PubMed ID: 27677195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical strategy for cholesteatoma in children.
    Ueda H; Nakashima T; Nakata S
    Auris Nasus Larynx; 2001 Apr; 28(2):125-9. PubMed ID: 11240319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost analysis and outcomes of a second-look tympanoplasty-mastoidectomy strategy for cholesteatoma.
    Crowson MG; Ramprasad VH; Chapurin N; Cunningham CD; Kaylie DM
    Laryngoscope; 2016 Nov; 126(11):2574-2579. PubMed ID: 26928951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Markers of epidermal proliferation in middle ear cholesteatoma].
    Hassmann-Poznańska E; Skotnicka B; Dziecioł J
    Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intact canal wall mastoidectomy with tympanoplasty for cholesteatoma in children.
    Dodson EE; Hashisaki GT; Hobgood TC; Lambert PR
    Laryngoscope; 1998 Jul; 108(7):977-83. PubMed ID: 9665242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma].
    Li S; Zhan H; Peng S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):987-91. PubMed ID: 19157151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
    Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of acquired cholesteatoma in patients with craniofacial anomalies: An institutional experience.
    Lourençone LFM; Batistão GT; de Cassia Rillo Dutka J; de Brito R
    Am J Otolaryngol; 2020; 41(6):102591. PubMed ID: 32634641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
    Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
    Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between postoperative recurrence and expression of cyclin E, p27, and Ki-67 in non-small cell lung cancer without lymph node metastases.
    Takahashi S; Kamata Y; Tamo W; Koyanagi M; Hatanaka R; Yamada Y; Tsushima T; Takaya S; Fukuda I
    Int J Clin Oncol; 2002 Dec; 7(6):349-55. PubMed ID: 12494250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Closed tympanoplasty in middle ear cholesteatoma surgery.
    Lesinskas E; Vainutiene V
    Medicina (Kaunas); 2004; 40(9):856-9. PubMed ID: 15456971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphopathogenesis of Adult Acquired Cholesteatoma.
    Dambergs K; Sumeraga G; Pilmane M
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837507
    [No Abstract]   [Full Text] [Related]  

  • 35. [Revisional radical mastoidectomy surgeries--25 cases'experience].
    Li L; Xie J; Liu Y; Gong SS
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Oct; 52(10):766-770. PubMed ID: 29050095
    [No Abstract]   [Full Text] [Related]  

  • 36. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Apoptotic vs Antiapoptotic Proteins in Middle Ear Cholesteatoma.
    Chung JH; Lee SH; Park CW; Kim KR; Tae K; Kang SH; Oh YH; Pyo JY
    Otolaryngol Head Neck Surg; 2015 Dec; 153(6):1024-30. PubMed ID: 26124267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten-year results of canal wall down mastoidectomy for acquired cholesteatoma.
    Vartiainen E
    Auris Nasus Larynx; 2000 Jul; 27(3):227-9. PubMed ID: 10808110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of intraoperative findings in revision tympanomastoidectomy.
    Košec A; Kelava I; Ajduk J; Ries M; Trotić R; Bedeković V
    Am J Otolaryngol; 2017; 38(4):462-465. PubMed ID: 28431842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.